Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology
- 15 January 2013
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (5) , 1941-1946
Abstract
Alzheimer’s disease (AD) is the most common cause of dementia worldwide. The pathogenesis of this neurodegenerative disease, currently without curative treatment, is associated with the accumulation of amyloid β (Aβ) in brain parenchyma and cerebral vasculature. AD patients are unable to clear this toxic peptide, leading to Aβ accumulation in their brains and, presumably, the pathology associated with this devastating disease. Compounds that stimulate the immune system to clear Aβ may therefore have great therapeutic potential in AD patients. Monophosphoryl lipid A (MPL) is an LPS-derived Toll-like receptor 4 agonist that exhibits unique immunomodulatory properties at doses that are nonpyrogenic. We show here that repeated systemic injections of MPL, but not LPS, significantly improved AD-related pathology in APP swe /PS1 mice. MPL treatment led to a significant reduction in Aβ load in the brain of these mice, as well as enhanced cognitive function. MPL induced a potent phagocytic response by microglia while triggering a moderate inflammatory reaction. Our data suggest that the Toll-like receptor 4 agonist MPL may be a treatment for AD.Keywords
This publication has 49 references indexed in Scilit:
- Ablation of TNF-RI/RII Expression in Alzheimer's Disease Mice Leads to an Unexpected Enhancement of PathologyThe American Journal of Pathology, 2011
- Decreased Clearance of CNS β-Amyloid in Alzheimer’s DiseaseScience, 2010
- Inflammation, microglia, and alzheimer's diseaseNeurobiology of Disease, 2010
- Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer diseaseExperimental Gerontology, 2010
- Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid AJournal of Biological Chemistry, 2009
- Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid depositionThe FASEB Journal, 2009
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvantCellular and Molecular Life Sciences, 2008
- Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathologyJournal of Clinical Investigation, 2007
- Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid FibrilsMolecular Biology of the Cell, 2007
- Role of toll-like receptor signalling in A uptake and clearanceBrain, 2006